📖
PHD Inhibitor Vadadustat: The First Drug Therapy for Triosephosphate Isomerase Deficiency.
Scalais E, Patel P, Satterfield S, Donge M, Laschiazza R, Sorlin A, Roberts P, Figura JR, Donahue ER, Cui C, Chambers M, McClure K, Coleman G, Kitamura N, Galligan JJ, Vollmer LL, Homanics GE, van Beers EJ, Vogt A, Palladino MJ

PHD Inhibitor Vadadustat: The First Drug Therapy for Triosephosphate Isomerase Deficiency.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Genes (Basel).

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title PHD Inhibitor Vadadustat: The First Drug Therapy for Triosephosphate Isomerase Deficiency.
Author / Organization Scalais E, Patel P, Satterfield S, Donge M, Laschiazza R, Sorlin A, Roberts P, Figura JR, Donahue ER, Cui C, Chambers M, McClure K, Coleman G, Kitamura N, Galligan JJ, Vollmer LL, Homanics GE, van Beers EJ, Vogt A, Palladino MJ
Subject & Discipline Genes (Basel)
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-268227
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »